DICER1-Associated Anaplastic Sarcoma of the Kidney With Coexisting Activating PDGFRA D842V Mutations and Response to Targeted Kinase Inhibitors in One Patient.
作者信息
Antonescu Cristina R, Reuter Victor E, Keohan Mary Lou, Hwang Sinchun, Chi Ping
机构信息
Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY.
Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
出版信息
JCO Precis Oncol. 2022 Jul;6:e2100554. doi: 10.1200/PO.21.00554.
Abstract
摘要
相似文献
1
DICER1-Associated Anaplastic Sarcoma of the Kidney With Coexisting Activating PDGFRA D842V Mutations and Response to Targeted Kinase Inhibitors in One Patient.1例伴有共激活型血小板衍生生长因子受体α（PDGFRA）D842V突变的肾DICER1相关性间变性肉瘤及对靶向激酶抑制剂的反应
JCO Precis Oncol. 2022 Jul;6:e2100554. doi: 10.1200/PO.21.00554.
2
Anaplastic sarcomas of the kidney are characterized by DICER1 mutations.肾脏的间叶性梭形细胞肉瘤的特征在于 DICER1 突变。
Mod Pathol. 2018 Jan;31(1):169-178. doi: 10.1038/modpathol.2017.100. Epub 2017 Sep 1.
3
Efficacy of Imatinib in Patients with Platelet-Derived Growth Factor Receptor Alpha-Mutated Gastrointestinal Stromal Tumors.伊马替尼对血小板衍生生长因子受体α突变型胃肠道间质瘤患者的疗效
Cancer Res Treat. 2016 Apr;48(2):546-52. doi: 10.4143/crt.2015.015. Epub 2015 Jun 22.
4
Anaplastic sarcoma of the kidney with DICER1 mutation: A case report.伴有DICER1突变的肾间变性肉瘤：一例报告。
Pediatr Int. 2022 Jan;64(1):e14851. doi: 10.1111/ped.14851. Epub 2021 Dec 12.
5
[Clinicopathological features and prognosis of gastrointestinal stromal tumor with PDGFRA-D842V mutation].[血小板衍生生长因子受体A基因D842V突变的胃肠道间质瘤的临床病理特征及预后]
Zhonghua Wei Chang Wai Ke Za Zhi. 2020 Sep 25;23(9):872-879. doi: 10.3760/cma.j.cn.441530-20200706-00405.
6
[Clinicopathological features and prognosis of 59 patients with platelet-derived growth factor α-mutant gastrointestinal stromal tumor].59例血小板衍生生长因子α突变型胃肠道间质瘤的临床病理特征及预后
Zhonghua Wei Chang Wai Ke Za Zhi. 2020 Sep 25;23(9):880-887. doi: 10.3760/cma.j.cn.441530-20200320-00156.
7
Integrated Molecular Characterization of Gastrointestinal Stromal Tumors (GIST) Harboring the Rare D842V Mutation in PDGFRA Gene.携带有 PDGFRA 基因罕见 D842V 突变的胃肠道间质瘤（GIST）的综合分子特征分析。
Int J Mol Sci. 2018 Mar 4;19(3):732. doi: 10.3390/ijms19030732.
8
ALK expressed in a gastrointestinal stromal tumor harboring PDGFRA p. D842V mutation:a case report.ALK 表达于携带有 PDGFRA p. D842V 突变的胃肠道间质瘤中：一例报告。
Diagn Pathol. 2020 Jan 31;15(1):8. doi: 10.1186/s13000-020-0926-x.
9
Effects of PKC412, nilotinib, and imatinib against GIST-associated PDGFRA mutants with differential imatinib sensitivity.PKC412、尼罗替尼和伊马替尼对具有不同伊马替尼敏感性的胃肠道间质瘤相关血小板衍生生长因子受体α（PDGFRA）突变体的作用。
Gastroenterology. 2006 Dec;131(6):1734-42. doi: 10.1053/j.gastro.2006.09.017. Epub 2006 Sep 20.
10
Anaplastic Sarcoma of Kidney and DICER1.肾间变性肉瘤与DICER1
Pediatr Dev Pathol. 2022 Sep-Oct;25(5):574. doi: 10.1177/10935266221111632. Epub 2022 Jun 28.
引用本文的文献
1
Anaplastic Sarcoma of the Kidney in a Child with Syndrome: A Case Report.一名患有[综合征名称]儿童的肾间变性肉瘤：病例报告
Surg Case Rep. 2025;11(1). doi: 10.70352/scrj.cr.25-0010. Epub 2025 Aug 14.
2
RAS pathway targeted therapy in patients with DICER1-associated sarcomas.DICER1相关肉瘤患者的RAS通路靶向治疗
NPJ Precis Oncol. 2025 Jul 9;9(1):232. doi: 10.1038/s41698-025-01026-0.
3
Alternative driver pathways in peripheral nerve sheath tumors - including DICER1 and/or KRAS alterations.外周神经鞘瘤中的替代驱动途径——包括DICER1和/或KRAS改变。
J Pathol. 2025 Mar;265(3):372-384. doi: 10.1002/path.6391. Epub 2025 Jan 23.
4
Hereditary Renal Cancer Syndromes.遗传性肾癌综合征。
Med Sci (Basel). 2024 Feb 18;12(1):12. doi: 10.3390/medsci12010012.
本文引用的文献
1
Avapritinib in advanced PDGFRA D842V-mutant gastrointestinal stromal tumour (NAVIGATOR): a multicentre, open-label, phase 1 trial.阿伐普利尼治疗晚期 PDGFRA D842V 突变胃肠间质瘤（NAVIGATOR）：一项多中心、开放标签、1 期临床试验。
Lancet Oncol. 2020 Jul;21(7):935-946. doi: 10.1016/S1470-2045(20)30269-2.
2
Embryonal Rhabdomyosarcoma of the Ovary and Fallopian Tube: Rare Neoplasms Associated With Germline and Somatic DICER1 Mutations.卵巢和输卵管胚胎性横纹肌肉瘤：与种系和体细胞 DICER1 突变相关的罕见肿瘤。
Am J Surg Pathol. 2020 Jun;44(6):738-747. doi: 10.1097/PAS.0000000000001442.
3
Avapritinib Approved for GIST Subgroup.阿伐替尼获批用于胃肠道间质瘤亚组。
Cancer Discov. 2020 Mar;10(3):334. doi: 10.1158/2159-8290.CD-NB2020-002. Epub 2020 Jan 23.
4
High Yield of RNA Sequencing for Targetable Kinase Fusions in Lung Adenocarcinomas with No Mitogenic Driver Alteration Detected by DNA Sequencing and Low Tumor Mutation Burden.高产量 RNA 测序在 DNA 测序未检测到有丝分裂驱动改变且肿瘤突变负担低的肺腺癌中发现可靶向的激酶融合。
Clin Cancer Res. 2019 Aug 1;25(15):4712-4722. doi: 10.1158/1078-0432.CCR-19-0225. Epub 2019 Apr 26.
5
Anaplastic sarcomas of the kidney are characterized by DICER1 mutations.肾脏的间叶性梭形细胞肉瘤的特征在于 DICER1 突变。
Mod Pathol. 2018 Jan;31(1):169-178. doi: 10.1038/modpathol.2017.100. Epub 2017 Sep 1.
6
Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients.从10000例患者的前瞻性临床测序中揭示的转移性癌症的突变图谱。
Nat Med. 2017 Jun;23(6):703-713. doi: 10.1038/nm.4333. Epub 2017 May 8.
7
Tumor progression in DICER1-mutated cystic nephroma-witnessing the genesis of anaplastic sarcoma of the kidney.DICER1突变型囊性肾瘤中的肿瘤进展——见证肾间变性肉瘤的发生
Hum Pathol. 2016 Jul;53:114-20. doi: 10.1016/j.humpath.2016.03.002. Epub 2016 Mar 29.
8
Exome sequencing of pleuropulmonary blastoma reveals frequent biallelic loss of TP53 and two hits in DICER1 resulting in retention of 5p-derived miRNA hairpin loop sequences.胸膜肺母细胞瘤的外显子组测序显示，TP53频繁发生双等位基因缺失，且DICER1出现两次突变，导致5p衍生的微小RNA发夹环序列保留。
Oncogene. 2014 Nov 6;33(45):5295-302. doi: 10.1038/onc.2014.150. Epub 2014 Jun 9.
9
Biallelic DICER1 mutations in sporadic pleuropulmonary blastoma.散发性胸膜肺胚细胞瘤中的双等位基因 DICER1 突变。
Cancer Res. 2014 May 15;74(10):2742-9. doi: 10.1158/0008-5472.CAN-13-2470. Epub 2014 Mar 27.
10
DICER1 mutations in childhood cystic nephroma and its relationship to DICER1-renal sarcoma.儿童囊性肾瘤中的DICER1突变及其与DICER1相关性肾肉瘤的关系。
Mod Pathol. 2014 Sep;27(9):1267-80. doi: 10.1038/modpathol.2013.242. Epub 2014 Jan 31.
Zotero 插件